TriSalus Life Sciences
TLSI
TLSI
9 hedge funds and large institutions have $17.3M invested in TriSalus Life Sciences in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 64 closing their positions.
Holders
9
Holders Change
-63
Holders Change %
-87.5%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
1
Reduced
3
Closed
64
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
VF
1
Virtu Financial
New York
|
$124K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$20.7K |
Top Sellers
1 |
1
BlackRock
New York
|
$0 |
2 |
DM
2
Deerfield Management
New York
|
$0 |
3 |
GCL
3
Glazer Capital LLC
New York
|
$0 |
4 |
![]()
4
Marshall Wace
London,
United Kingdom
|
$0 |
5 |
5
HSBC Holdings
London,
United Kingdom
|
$0 |